| تعداد نشریات | 286 |
| تعداد نشریات سازمان | 84 |
| تعداد شماره‌ها | 3,006 |
| تعداد مقالات | 33,642 |
| تعداد مشاهده مقاله | 44,579,504 |
| تعداد دریافت فایل اصل مقاله | 31,706,444 |
Human and animal intestinal commensals and probiotics vs modern challenges of biosafety: problems and prospects | ||
| Archives of Razi Institute | ||
| مقاله 4، دوره 79، شماره 1، فروردین و اردیبهشت 2024، صفحه 28-32 اصل مقاله (190.53 K) | ||
| نوع مقاله: Mini Review | ||
| شناسه دیجیتال (DOI): 10.32592/ARI.2024.79.1.28 | ||
| نویسندگان | ||
| Vladislav Chernov1؛ Olga Chernova1؛ Maxim Trushin* 2 | ||
| 1Kazan Institute of Biochemistry and Biophysics of the Kazan Scientific Center of the Russian Academy of Sciences, Kazan, Russian Federation | ||
| 2Kazan Federal University | ||
| چکیده | ||
| The appearance of an array of data on the study of the intestinal microbiota in Metazoa has significantly expanded our understanding of the role of commensals in the control of a wide range of physiological functions in higher organisms in norm and pathology. In the intestine, where the microbial load significantly exceeds the number of microorganisms of other ecosystems, the components of the intestinal microbiota are a constant source of stimuli that induce activation of the host immune systemThe introduction into practice of biomedical research of innovative high-resolution methods, including multi-omix technologies, has brought data that change our understanding of intestinal commensals, including probiotics with GRAS status, widely used in medicine, agriculture and biotechnology. The ability of these bacteria to induce negative processes in the host body that are beneficial for bacterial proliferation and expansion revealed a clear lack of our knowledge about the logic of their life and the mechanisms of interaction with eukaryotic cells. This determines the urgent need for comprehensive research of probiotics and the development of standardization of their safety assessment. Apriori's confidence in the exceptional benefit of the bacteria widely used in medicine, agriculture and biotechnology has determined the seriously omission in our control system today - the lack of standardization of studies for the safety assessment of bacteria with GRAS status . The moment has come when it became clear that this gap should be promptly filled and that only exact understanding the molecular base of interacting the microbes with eukaryotic cells can provide the foundation for effective practical developments in controlling the evolution of bacterial virulence and probiotic safety strategy, as well as the competent use of genetic technologies for monitoring the environment and managing infectious processes, thus avoiding the dramatic consequences of large-scale interventions in the micro and macro worlds. | ||
| کلیدواژه‌ها | ||
| intestinal commensals؛ probiotics؛ innovation technologies؛ probiotic-host crosstalk؛ biosafety | ||
|
سایر فایل های مرتبط با مقاله
|
||
| مراجع | ||
|
References 1. Westermann AJ, Vogel J. Cross-species RNA-seq for deciphering host-microbe interactions // Nat Rev Genet. 2021 Jun;22(6):361-378. 2. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system // Science. 2012 Jun 8;336(6086):1268-73. 3. Sebastián Domingo JJ, Sánchez Sánchez C. From the intestinal flora to the microbiome. // Rev Esp Enferm Dig. 2018 Jan;110(1):51-56. 4. Postler TS, Ghosh S. Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System // Cell Metab. 2017 Jul 5;26(1):110-130. 5. Marchesi JR. Advancing microbiome research // Microbiology (Reading). 2018;164(8):1005-1006. 6. Doron S, Snydman DR. Risk and safety of probiotics // Clin Infect Dis. 2015; 60 Suppl 2(Suppl 2):S129-34. 7. Bodke H, Jogdand S. Role of Probiotics in Human Health // Cureus. 2022 Nov 9;14(11):e31313. 8. Rosenberg E, Zilber-Rosenberg I. The hologenome concept of evolution after 10 years // Microbiome. 2018;6(1):78. 32 Chernov et al / Archives of Razi Institute, Vol. 79, No. 1 (2024) 28-32 9. Diard M, Hardt WD. Evolution of bacterial virulence // FEMS Microbiol Rev. 2017;41(5):679-697. 10. Mendes I, Vale N How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy? // Int J Mol Sci. 2023;24(14):11855. 11. Xu W, Fang Y, Hu Q, Zhu K. Emerging Risks in Food: Probiotic Enterococci Pose a Threat to Public Health through the Food Chain // Foods. 2021 ;10(11):2846. 12. Li HY, Zhou DD, Gan RY, Huang SY, Zhao CN, Shang A, Xu XY, Li HB. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review. // Nutrients. 2021;13(9):3211. 13. Sukhvinder Gill, Ryan Catchpole, Patrick Forterre Extracellular membrane vesicles in the three domains of life and beyond //FEMS Microbiol Rev. 2019; 43(3): 273– 303. 14. Alexander LM, van Pijkeren JP. Modes of therapeutic delivery in synthetic microbiology // Trends Microbiol. 2023;31(2):197-211. 15. Tian CM, Yang MF, Xu HM, Zhu MZ, Zhang Y, Yao J, Wang LS, Liang YJ, Li DF. Emerging role of bacterial outer membrane vesicle in gastrointestinal tract // Gut Pathog. 2023;15(1):20. 16. Li XY, Zeng ZX, Cheng ZX, Wang YL, Yuan LJ, Zhai ZY, Gong W. Common pathogenic bacteria-induced reprogramming of the host proteinogenic amino acids metabolism. Amino Acids. 2023 Oct 9. Epub ahead of print. PMID: 37814028. 17. Gottfried S, Koloamatangi SMBMJ, Daube C, Schiemann AH, Sattlegger E. A genetic approach to identify amino acids in Gcn1 required for Gcn2 activation // PLoS One. 2022;17(11):e0277648. 18. Ghosh JC, Perego M, Agarwal E, Bertolini I, Wang Y, Goldman AR, Tang HY, Kossenkov AV, Landis CJ, Languino LR, Plow EF, Morotti A, Ottobrini L, Locatelli M, Speicher DW, Caino MC, Cassel J, Salvino JM, Robert ME, Vaira V, Altieri DC Ghost mitochondria drive metastasis through adaptive GCN2/Akt therapeutic vulnerability // Proc Natl Acad Sci U S A. 2022;119(8):e2115624119. 19. Markova ND. L-form bacteria cohabitants in human blood: significance for health and diseases // Discov Med. 2017; 23(128):305-313. 20. Errington J. Cell wall-deficient, L-form bacteria in the 21st century: a personal perspective // Biochem Soc Trans. 2017;45(2):287-295. 21. Kostenko VV, Mouzykantov AA, Baranova NB, Boulygina EA, Markelova MI, Khusnutdinova DR, Trushin MV, Chernova OA, Chernov VM. Development of Resistance to Clarithromycin and Amoxicillin-Clavulanic Acid in Lactiplantibacillus plantarum In Vitro Is Followed by Genomic Rearrangements and Evolution of Virulence. Microbiol Spectr. 2022 Jun 29;10(3):e0236021. Epub 2022 May 17. PMID: 35579444; PMCID: PMC9241834. 22. Merenstein D, Pot B, Leyer G, Ouwehand AC, Preidis GA, Elkins CA, Hill C, Lewis ZT, Shane AL, Zmora N, Petrova MI, Collado MC, Morelli L, Montoya GA, Szajewska H, Tancredi DJ, Sanders ME. Emerging issues in probiotic safety: 2023 perspectives // Gut Microbes. 2023;15(1):2185034. 23. Adak A, Khan MR. An insight into gut microbiota and its functionalities // Cell Mol Life Sci. 2019;76(3):473-493. 24. Liang X, Li Y, Zhao Z, Ding R, Sun J, Chi C. Safety and efficacy of adding postbiotics in infant formula: a systematic review and meta-analysis. Pediatr Res. 2023. PMID: 37700163. 25. Mjelle R, Aass KR, Sjursen W, Hofsli E, Sætrom P. sMETASeq: Combined Profiling of Microbiota and Host Small RNAs. iScience. 2020 May 22;23(5):101131. Epub 2020 May 4. PMID: 32422595; PMCID: PMC7229328. | ||
|
آمار تعداد مشاهده مقاله: 11,482 تعداد دریافت فایل اصل مقاله: 3,094 |
||
